A low dose of levodopa is generally 300 mg or less per day, split across multiple doses. Most people start even lower than that, at 100 mg of levodopa taken three times daily (300 mg total), and many clinicians begin with just 100 mg twice daily when first prescribing the medication for Parkinson’s disease. The goal of starting low is to find the smallest amount that meaningfully controls symptoms while minimizing side effects.
What the Starting Dose Looks Like
Levodopa is almost always prescribed in combination with carbidopa, a companion drug that prevents levodopa from breaking down before it reaches the brain. When you see a dose written as “25/100,” the first number is carbidopa and the second is levodopa. For most people new to the medication, the standard starting point is one 25/100 tablet taken three times a day. That works out to 300 mg of levodopa per day.
Some prescribers start even lower, at one 25/100 tablet twice daily (200 mg of levodopa total), and increase from there. Extended-release versions typically begin at one 50/200 tablet twice daily, though the body absorbs less of the levodopa from these formulations, so the effective dose isn’t as high as the number suggests. The key principle across all formulations is the same: begin at the low end and work upward.
How “Low” Compares to Higher Doses
Context helps here. People with advanced Parkinson’s disease sometimes take 1,000 mg or more of levodopa per day, divided into multiple doses throughout the day. Against that backdrop, anything in the 200 to 400 mg range is genuinely low. A post hoc analysis from the STRIDE-PD study identified daily doses above 400 mg as a risk factor for developing dyskinesia, the involuntary movements that can emerge with long-term levodopa use. That 400 mg threshold is one reason many clinicians try to keep patients at or below it for as long as symptoms allow.
In practice, “low dose” isn’t a single fixed number. It depends on where someone is in their disease. For a person just diagnosed, 300 mg per day may be plenty. For someone who has been on the medication for years, 400 mg might be considered relatively low compared to where their dose has been heading.
Available Tablet Strengths
The standard immediate-release carbidopa/levodopa tablet comes in three strengths:
- 10/100: 10 mg carbidopa, 100 mg levodopa
- 25/100: 25 mg carbidopa, 100 mg levodopa
- 25/250: 25 mg carbidopa, 250 mg levodopa
The 25/100 tablet is the workhorse for low-dose therapy. The 10/100 version delivers the same amount of levodopa but less carbidopa, which means slightly less protection against nausea and other peripheral side effects. The 25/250 tablet is typically reserved for people who need a higher dose per pill and isn’t part of most low-dose regimens.
Why Doses Are Spread Throughout the Day
Levodopa doesn’t last long in the body. The immediate-release form peaks within about an hour and wears off within a few hours. That’s why even a low total daily dose is divided into multiple smaller doses taken every three to four hours during waking hours. Taking 300 mg all at once wouldn’t provide steady symptom control, and it would be more likely to cause nausea or dizziness.
Three times daily is the most common starting frequency. As the disease progresses and each dose wears off more quickly, people often shift to taking smaller amounts more frequently rather than simply increasing the size of each dose.
How Doses Increase Over Time
Starting low doesn’t mean staying low forever. Parkinson’s is progressive, and most people need gradual increases over months and years. The typical approach is to add one extra tablet per day (an additional 100 mg of levodopa) every few days to weeks, depending on how well symptoms respond and how the person tolerates the medication. This slow upward adjustment gives the body time to adapt and helps identify the minimum effective dose at each stage.
Early on, the adjustments tend to be small and infrequent. A person might stay at 300 mg daily for months or even a year before needing more. Later in the disease, increases may come more often. The pace varies widely from person to person.
Why Starting Low Matters
The “start low, go slow” approach exists for two practical reasons. First, levodopa commonly causes nausea, lightheadedness, and drowsiness when the body isn’t used to it. Starting with smaller amounts lets these side effects emerge mildly rather than hitting all at once. Most people adjust within a few weeks.
Second, there’s the long-term concern about dyskinesia. Higher cumulative doses over time are associated with a greater chance of developing these involuntary movements. Keeping the daily dose as low as possible for as long as it still controls symptoms is a strategy to delay that complication. The 400 mg daily threshold identified in research isn’t a hard cutoff where problems suddenly begin, but it’s a useful benchmark. Many clinicians aim to keep patients below it during the earlier years of treatment, increasing only when symptoms clearly demand it.